CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
May 2nd 2025
New results from a breast cancer-related lymphedema study show the importance of measuring fluid and body composition before treatment begins.
Young Breast Cancer Survivors Empowered Through Advocacy and Education
December 11th 2017“It was frustrating always being the youngest one in the waiting room, combined with the fact that there is just not a lot of data on this population. So, we are forced to make decisions in the absence of hard data. It’s frustrating to know that we’re the neglected cohort of the disease,” Petrides said.
How Many Weeks of Adjuvant Herceptin Is Optimal for People with HER2-Positive Breast Cancer?
December 8th 2017A phase 3 clinical trial pitted a nine-week treatment of adjuvant Herceptin against the regimen of a full year of treatment for patients with HER2-positive breast cancer. Results show that the standard treatment of one year is still optimal.
Controversial Breast Cancer Treatment Strategy May Protect Ovarian Function, Preserve Fertility
December 7th 2017A reveiw of five clinical trial findings suggests that gonadotropin-releasing hormone analog has the potential to preserve ovarian function and fertility in premenopausal breast cancer patients.
Kisqali Extends Progression-Free Survival for Premenopausal Breast Cancer Subsets
December 7th 2017New research demonstrates that a CDK4/6 inhibitor, used in combination with standard endocrine therapy with temporary ovarian suppression significantly improves progression-free survival in younger patients who currently have few treatment options.
Alternative Chemotherapy Dosing Strategies Improve Breast Cancer Outcomes
December 6th 2017For women with early-stage breast cancer who are receiving chemotherapy, shortening the time between treatment cycles or administering the agents sequentially may reduce disease recurrence and mortality compared with standard chemotherapy regimens.
Treatment Options Expanding in HER2-Positive Breast Cancer
December 4th 2017Treatment options for patients with HER2-positive breast cancer continue to expand, especially after the Food and Drug Administration (FDA) approval of Nerlynx (neratinib) earlier in 2017 and the more recent priority review designation of Perjeta (pertuzumab).
How Do You Retire a Prosthesis?
November 26th 2017Silicone doesn't last forever. After a few years of constant wear, a prosthesis breaks down and is no longer functional. Some women become very attached to their replacement breasts and find it difficult to say goodbye. This is one survivor's light hearted look at what to do with worn out breast forms.
Make Collecting Family Health History Part of Your Thanksgiving Plans
November 17th 2017For some, being home for the holidays means lots of extra family time. Bright Pink, a national nonprofit focused on the prevention and early detection of breast and ovarian cancer, shares how women can take advantage of this opportunity to enrich their knowledge about their family's health history.